| scholarly article | Q13442814 |
| P50 | author | Daniela Pitigoi | Q56486864 |
| Antonino Bella | Q88369195 | ||
| Anne Mosnier | Q125269649 | ||
| Caterina Rizzo | Q37366708 | ||
| Raquel Guiomar | Q42233608 | ||
| Baltazar Nunes | Q42233620 | ||
| P2093 | author name string | Alain Moren | |
| Anne-Sophie Barret | |||
| Beatrix Oroszi | |||
| Camelia Savulescu | |||
| Esther Kissling | |||
| Joan O'Donnell | |||
| Marta Valenciano | |||
| Emilia Lupulescu | |||
| Piotr Kramarz | |||
| Amparro Larrauri Cámara | |||
| Bruno C Ciancio | |||
| Jean-Marie Cohen | |||
| Judith K Horvath | |||
| P2860 | cites work | Early pandemic influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis | Q28473959 |
| Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. | Q30227381 | ||
| Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. | Q30357784 | ||
| First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States. | Q30372912 | ||
| Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. | Q30379529 | ||
| Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. | Q30380578 | ||
| Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City | Q30381410 | ||
| Estimating influenza vaccine effectiveness using routinely collected laboratory data. | Q30382480 | ||
| Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. | Q30382490 | ||
| "I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. | Q30382891 | ||
| Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. | Q30383579 | ||
| Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada | Q30388012 | ||
| Efficiency of seasonal influenza vaccine in persons older than 65 in Romania. Pilot case-control study I-MOVE, 2008-2009 | Q30388586 | ||
| Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. | Q30389024 | ||
| Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. | Q30391398 | ||
| Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case–control study | Q30394200 | ||
| Estimation of influenza vaccine effectiveness from routine surveillance data | Q33424462 | ||
| Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls | Q33476068 | ||
| Traditional reviews, meta-analyses and pooled analyses in epidemiology | Q33589615 | ||
| Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls | Q34215438 | ||
| Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study | Q37233634 | ||
| Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain | Q45792636 | ||
| Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season | Q46159620 | ||
| Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. | Q48071872 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pandemic | Q12184 |
| multicenter clinical trial | Q6934595 | ||
| influenza vaccine | Q383260 | ||
| 2009 swine flu pandemic | Q101452 | ||
| vaccine | Q134808 | ||
| P304 | page(s) | e1000388 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | PLOS MEDICINE | Q1686921 |
| P1476 | title | Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study | |
| P478 | volume | 8 |
| Q34657959 | 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study. |
| Q30417900 | Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom |
| Q30396488 | Assessing the State of Knowledge Regarding the Effectiveness of Interventions to Contain Pandemic Influenza Transmission: A Systematic Review and Narrative Synthesis |
| Q30411303 | Assessment of the variability in influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approach |
| Q64245361 | Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations |
| Q35661715 | Clinical effectiveness of split-virion versus subunit trivalent influenza vaccines in older adults |
| Q30413695 | Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion |
| Q30411896 | Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway--and the influence of vaccination timing |
| Q24614487 | Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses |
| Q30408530 | Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case-control study |
| Q34805068 | Effectiveness of A(H1N1)pdm09 influenza vaccine in adults recommended for annual influenza vaccination |
| Q30399334 | Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. |
| Q30418619 | Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study |
| Q57210380 | Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study |
| Q34707079 | Effectiveness of MF59™ adjuvanted influenza A(H1N1)pdm09 vaccine in risk groups in the Netherlands |
| Q30404989 | Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study |
| Q30402040 | Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden |
| Q28741469 | Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities |
| Q28743357 | Effectiveness of pandemic H1N1-2009 vaccination in reducing laboratory confirmed influenza infections among military recruits in tropical Singapore |
| Q30367263 | Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland. |
| Q30419179 | Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization |
| Q30414952 | Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study |
| Q46625048 | Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study |
| Q30405205 | Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A/(H1N1) 2009--a comparison of two methods; Germany, 2009/10. |
| Q30419503 | Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza |
| Q30404419 | Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. |
| Q30406619 | Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study. |
| Q30410814 | Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice |
| Q30429825 | Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010. |
| Q30408691 | Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis |
| Q42210257 | Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups. |
| Q30409739 | Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010. |
| Q82234052 | Estimating the effect of influenza vaccines |
| Q34550913 | Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan |
| Q30151954 | European decision-maker perspective with regard to influenza prevention policies |
| Q42270731 | Evaluation and sensitivity analysis of the effectiveness of unadjuvanted A(H1N1)pdm09 vaccine in hospital workers using multi-center cohort study in Korea |
| Q30393380 | Evaluation of Influenza Vaccination Efficacy: A Universal Epidemic Model. |
| Q30400117 | Factors associated with parental acceptance and refusal of pandemic influenza A/H1N1 vaccine in Turkey |
| Q30402693 | Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France |
| Q37619140 | From discovery to licensure, the Adjuvant System story |
| Q30388367 | Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide [...] |
| Q44872663 | Henoch-Schönlein purpura following influenza A H1N1 vaccination |
| Q30408845 | High effectiveness of pandemic influenza A (H1N1) vaccination in healthcare workers from a Portuguese hospital |
| Q28742719 | I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe |
| Q39813822 | I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination? |
| Q30413786 | Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses. |
| Q40459298 | Individual Vaccination as Nash Equilibrium in a SIR Model with Application to the 2009-2010 Influenza A (H1N1) Epidemic in France. |
| Q30411868 | Influenza vaccination coverage rate in children: reasons for a failure and how to go forward |
| Q30354181 | Influenza vaccination in India: position paper of Indian Academy of Pediatrics, 2013. |
| Q41612054 | Influenza vaccine effectiveness estimates in Croatia in 2010-2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus |
| Q40765540 | Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season. |
| Q35608431 | Influenza vaccine prevents medically attended influenza-associated acute respiratory illness in adults aged ≥50 years |
| Q27027029 | Influenza virus vaccines: lessons from the 2009 H1N1 pandemic |
| Q36343637 | Is the impact of childhood influenza vaccination less than expected: a transmission modelling study |
| Q30401787 | Learning lessons from the 2009 pandemic: putting infections in their proper place |
| Q30427501 | Live attenuated seasonal and pandemic influenza vaccine in school-age children: a randomized controlled trial |
| Q91652152 | Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort |
| Q30413547 | Mammalian-transmissible H5N1 influenza: facts and perspective |
| Q44243917 | Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. |
| Q39422605 | Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan |
| Q30417347 | Nurses' vaccination against pandemic H1N1 influenza and their knowledge and other factors |
| Q30421549 | PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries |
| Q30413569 | Pandemic and seasonal vaccine coverage and effectiveness during the 2009-2010 pandemic influenza in an Italian adult population |
| Q30431452 | Pandemic influenza A(H1N1)pdm09: risk of infection in primary healthcare workers |
| Q30387431 | Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season: the Nordic experience |
| Q30371873 | Partial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and meta-analyses. |
| Q51165360 | Patterns of spread of influenza A in Canada. |
| Q34778408 | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review |
| Q30417417 | Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls |
| Q30407650 | Prospects for controlling future pandemics of influenza |
| Q35606494 | Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages |
| Q30417601 | Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial |
| Q30373830 | Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios |
| Q30389099 | Public preferences for vaccination programmes during pandemics caused by pathogens transmitted through respiratory droplets - a discrete choice experiment in four European countries, 2013. |
| Q37998104 | Risk factors and effectiveness of preventive measures against influenza in the community |
| Q30405652 | Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico |
| Q47219641 | School-Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program |
| Q30414225 | Sociodemographic factors and clinical conditions associated to hospitalization in influenza A (H1N1) 2009 virus infected patients in Spain, 2009-2010. |
| Q30235320 | The ADVANCE Code of Conduct for collaborative vaccine studies |
| Q41263011 | The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). |
| Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
| Q36131193 | The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines |
| Q30411857 | The importance of influenza prevention for public health |
| Q30414430 | Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway |
| Q30410112 | Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. |
| Q30224045 | Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands |
| Q30409727 | Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study |
| Q24201525 | Vaccines for preventing influenza in healthy children |
| Q47638511 | Vaccines for preventing influenza in healthy children |
| Q38803189 | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies |
| Q30226747 | We should not be complacent about our population-based public health response to the first influenza pandemic of the 21st century |
Search more.